Cargando…
Sphingolipid lysosomal storage diseases: from bench to bedside
Johann Ludwig Wilhelm Thudicum described sphingolipids (SLs) in the late nineteenth century, but it was only in the past fifty years that SL research surged in importance and applicability. Currently, sphingolipids and their metabolism are hotly debated topics in various biochemical fields. Similar...
Autores principales: | Abed Rabbo, Muna, Khodour, Yara, Kaguni, Laurie S., Stiban, Johnny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094529/ https://www.ncbi.nlm.nih.gov/pubmed/33941173 http://dx.doi.org/10.1186/s12944-021-01466-0 |
Ejemplares similares
-
Sphingolipids in Inflammation: From Bench to Bedside
por: Kitatani, Kazuyuki, et al.
Publicado: (2016) -
Abnormal Sphingolipid World in Inflammation Specific for Lysosomal Storage Diseases and Skin Disorders
por: Moskot, Marta, et al.
Publicado: (2018) -
Implications of Membrane Binding by the Fe-S Cluster-Containing N-Terminal Domain in the Drosophila Mitochondrial Replicative DNA Helicase
por: So, Minyoung, et al.
Publicado: (2021) -
Research in Sickle Cell Disease: From Bedside to Bench to Bedside
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2021) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)